omega-n-methylarginine has been researched along with tcv 309 in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (tcv 309) | Trials (tcv 309) | Recent Studies (post-2010) (tcv 309) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 68 | 2 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, F; Imai, T; Morita, T; Saito, S; Shiga, T; Yoshikawa, D | 1 |
1 other study(ies) available for omega-n-methylarginine and tcv 309
Article | Year |
---|---|
Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat.
Topics: Animals; Blood Pressure; Blood Vessels; Decerebrate State; Endotoxins; Enzyme Inhibitors; In Vitro Techniques; Isoquinolines; Male; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetrahydroisoquinolines; Vasoconstrictor Agents | 1998 |